Download PDF
Thromb Haemost 1969; 22(02): 398-400
DOI: 10.1055/s-0038-1651421
Vorläufige Mitteilungen — Preliminary Reports — Communications Préliminaires
Schattauer GmbH

Fibrin Crosslinking Demonstrated by Thrombelastography

H. M Tyler
1   Biochemical Group, Therapeutics Research Division, Pfizer Ltd., Sandwich, Kent
› Author Affiliations
Further Information

Publication History

Publication Date:
10 June 2018 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Hartert H. Die thrombelastographic. Eine methode zur physikalischen analyse des blutge-rinnungsvorgangs. Z. ges. exp. Med. 117: 189 1951;
    CrossrefPubMedGoogle Scholar
  • 2 Marchai G, Leroux M. E, Samanta M. Atlas de Thrombodynamographie. Ed. S. P. E. I.; Paris: 1962
    Google Scholar
  • 3 Astrup T, Egeblad K. Thrombelastographic patterns produced by fibrinolytic agents incorporated in fibrin. Amer. J. Physiol. 209: 84 1965;
    PubMedGoogle Scholar
  • 4 Egeblad K, Astrup T. Effects of human plasma on thrombelastographic patterns produced by fibrinolytic agents in fibrin clots. Brit. J. Haemat. 13: 10 1967;
    CrossrefPubMedGoogle Scholar
  • 5 Egeblad K. Inhibitors of fibrinolysis: A comparative study. Scand. J. clin. Lab. Invest. 20: Suppl. 98 (1967)
    PubMedGoogle Scholar
  • 6 Duchert F, Jung E, Shmerling D. H. A. A hitherto undescribed congenital haemorrhagic diathesis probably due to F. S. F. deficiency. Thrombos. Diathes. haemorrh. (Stuttg.) 5: 179 1960;
    PubMedGoogle Scholar
  • 7 Duchert F. The fibrin stabilizing factor (FSF). Scand. J. Haemat. (Suppl.) series Haematolo-gica 7: 58 1965;
    PubMedGoogle Scholar
  • 8 Mandelli F. Sindrome emorragica da difetto del Fatore stabilizzante fibrinico di Laki e Lo-rand. Med. clin. sper. 13: 175 1963;
    PubMedGoogle Scholar
  • 9 Josso F, Prou-Wartelle O, Alagille D, Soulier T. P. Le déficit congenital en facteur stabilisant de la fibrine (Facteur XIII). Etude de deux cas. Nouv. Rev. franc. Hemat. 4: 267 1964;
    PubMedGoogle Scholar
  • 10 Qormsen J, Siversten U. The effect of -SH inhibitors and glycine derivatives on fibrin polymerisation and the physical strength of fibrin in plasma. Thrombos. Diathes. haemorrh. (Stuttg.) 11: 454 1964;
    PubMedGoogle Scholar
  • 11 Josso F, Faure A. La transformation du fibrinogène en fibrine II. Polymerization de la fibrine. Nouv. Rev. franc. Hemat. 5: 316 1965;
    PubMedGoogle Scholar
  • 12 Laki K. The polymerization of proteins. The action of thrombin on fibrinogen. Arch. Biochem. 32: 317 1951;
    CrossrefPubMedGoogle Scholar
  • 13 Loewy A. G, Dunathan K, Kriel R, Wolfinger H. L. Fibrinase I. Purification of substrate and enzyme. J. biol. Chem. 236: 2625 1961;
    PubMedGoogle Scholar
  • 14 Tyler H. M. A comparative study of the solvents commonly used to detect fibrin stabilization. Thrombos. Diathes. haemorrh. (Stuttg.) 16: 61 1966;
    PubMedGoogle Scholar
  • 15 Loewy A. G, Veneziale G, Forman M. Purification of the factor involed in the formation of urea-insoluble fibrin. Biochim. biophys. Acta. (Amst.) 26: 670 1957;
    CrossrefPubMedGoogle Scholar
  • 16 Tyler H. M, Laki K. Purification and properties of a fibrin crosslinking transamidase from rabbit liver. Biochemistry 6: 3259 1967;
    CrossrefPubMedGoogle Scholar